DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Lilly Pressemitteilung.
Lilly's Verzenio® (abemaciclib) Significantly Extended Life in Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2. (30.7.2019).
Im Internet:
https://investor.lilly.com/news-releases/news-release-details/lillys-verzenior-abemaciclib-significantly-extended-life-women . Stand: 21.10.2019
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.